Experts are divided on whether the shift towards private care is good or bad for the public health service in the long term
Increases in doctors’ bills, insurance and ‘lifestyle diseases’ are expected to boost hospital revenues
Experts warn better data is required to drive policy as debilitating condition reduces workforce
Boom in healthcare borrowing prompts warnings from doctors and campaigners
An FT special report looking at changes in healthcare, treatments and illness itself
For stretched public health budgets, high-tech treatments are hard to afford but some pre-emptive measures can prove good value
Caseloads of cancer and other illnesses of ageing are forecast to rise steeply in lower income countries
Wellcome’s John-Arne Røttingen says divisions risk harming action on pandemic responses and ‘superbugs’
Dentists says ‘punitive targets’ under NHS contract system are stifling delivery across the country
The retailer is right to cut losses and shut its healthcare centres and telehealth operation
Work and pensions secretary Mel Stride calls for ‘adult conversation’ around making system more sustainable
Cost of settling litigation in US over faulty machines is less than what market had expected
Government says it met Virgin O2 chief executive and Ofcom after incidents last year
Neglecting women’s pain affects the entire medical pipeline, from research to diagnosis and treatment
A population equivalent in size to Greater Manchester is not working due to ill health, at a huge and avoidable cost
Research harnesses power of generative artificial intelligence in latest sign of its potential use in medicine
PM’s intervention comes after report finds ‘remarkably weak evidence’ surrounding medical interventions
US healthcare company is putting cash to work from spinning off its consumer health arm
Research forecasts global deaths from the disease will almost double in 20 years
Transformative changes are still 10 to 15 years away, experts predict
Funding needed to drive innovation and make therapies available to all, says co-discoverer Jennifer Doudna
Ruth McKernan aims to make country a hub for research into the condition and accelerate development of new drugs
One-year-old healthcare start-up gains investment from venture groups including General Catalyst and Andreessen Horowitz
Worldwide study finds neurological conditions affect billions as life expectancy rises
Industry regulator has shut 804 for-profit facilities since 2011, study shows
International Edition